focus -WSS

focus

author：leisure time 2025-10-01 23:03:50 - browse：987

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Coloradans with cystic fibrosis could lose access to Trikafta

WSS

How to convince healthy people to buy insurance

Kidney transplant patients stopped immunosuppressants in trial

After Sarepta trial failure, Duchenne families brace for more debate

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Kidney transplant patients stopped immunosuppressants in trial

DeepMind touts AlphaFold's new skills as protein folding AI models face off

focus

focus

focus

BioMarin wins approval for gene therapy to treat hemophilia A

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

23andMe had bad news about my health. I wish a person had delivered it

Travis Kelce and the trap of celebrity vaccine endorsements

BioMarin wins approval for gene therapy to treat hemophilia A

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

Walensky prepares to leave CDC — and Congress — behind

All of Us, NIH's precision medicine initiative, gets a big boost

Hepatitis C has a cure — but many Americans still lack access to it

Inari Medical to buy amputation prevention company LimFlow

focus

Medical mystery: When an infection after surgery isn’t what it seems

Rock icon Freddie Mercury pre

How to convince healthy people to buy insurance

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

Live blog: Hearing on CRISPR

Brain injuries and the importance of a second opinion

knowledge

hotspot

knowledge

explore